Luis
García Ortiz
Profesor Asociado CC. Salud
Iuliu Hațieganu University of Medicine and Pharmacy
Cluj, RumaníaPublications en collaboration avec des chercheurs de Iuliu Hațieganu University of Medicine and Pharmacy (2)
2019
-
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
The Lancet, Vol. 394, Núm. 10193, pp. 121-130
-
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
The Lancet, Vol. 394, Núm. 10193, pp. 131-138